| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |